Dr Wafa Al-Jamal completed her PhD in Drug Delivery and Nanomedicine in 2008 from the School of Pharmacy, University of London (now known as UCL-School of Pharmacy). She is currently a Reader in Nanomedicine and Drug Delivery at Queen’s University Belfast, School of Pharmacy, UK. She is also a Prostate Cancer Research Fellow. Dr Al-Jamal joined the University of East Anglia, Norwich, as a Lecturer in Drug Delivery (2013-2017), after working as a Senior Research Fellow at University College London and King’s College London (2008-2013).
Dr Al-Jamal’s main research interest focuses on engineering novel nanomaterials for biomedical applications. Her current research, in Cancer Nanomedicine, aims to design smart vectors to deliver a wide range of therapeutic agents and targeting moieties, and to fabricate multifunctional nanoparticles for combinatory therapy and theranostic applications. Her long-term research career is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic. Dr Al-Jamal is the GSK Emerging Scientist Award winner for 2015, and Gro Brundtland Award winner for 2017. Currently, she is a Visiting Professor at Guizhou Medical School, China.